Intelligent Bio Solutions Inc. (NASDAQ:INBS) · earnings preview
Quarter
Q1
EPS estimate to actual
-$1.31
Revenue estimate to actual
$1.4M
At a glance
Key takeaways
01Intelligent Bio Solutions (INBS) reports Q1 earnings November 11, 2026 after market close, with analysts expecting EPS of -$1.31 versus -$0.00 last year.
02Revenue is projected at $1.4M, representing growth from the prior year quarter, though the company remains unprofitable.
03INBS stock trades at $2.23 with a $4.7M market capitalization, and recent earnings have beaten expectations by 34-43% due to smaller losses than estimated.
04The company has reported consecutive quarterly losses ranging from -$0.86 to -$2.82 per share over the past year.
Earnings Results
Intelligent Bio Solutions Inc. (NASDAQ:INBS) is scheduled to report its Q1 earnings results on November 11, 2026 after market close.
Analysts expect the Healthcare company to report earnings per share of $-1.31, below the $0.00 reported in the same quarter last year. Revenue is expected to come in at $1.4M, up from a year ago.
Company Overview
The stock currently trades at $2.23 with a market capitalization of $4.7M.
Ahead of Intelligent Bio Solutions Inc.'s earnings report, investors are watching several key metrics beyond the headline EPS number. Revenue growth, margin trends, and forward guidance will likely carry more weight than a single quarter's earnings figure in determining the stock's direction after the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Intelligent Bio Solutions Inc. should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.